151 related articles for article (PubMed ID: 30297765)
1. Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes.
Shalom B; Farago M; Pikarsky E; Katzav S
Oncogenesis; 2018 Oct; 7(10):80. PubMed ID: 30297765
[TBL] [Abstract][Full Text] [Related]
2. Vav1 mutations: What makes them oncogenic?
Farago M; Yarnitzky T; Shalom B; Katzav S
Cell Signal; 2020 Jan; 65():109438. PubMed ID: 31654719
[TBL] [Abstract][Full Text] [Related]
3. Vav1: A Dr. Jekyll and Mr. Hyde protein--good for the hematopoietic system, bad for cancer.
Katzav S
Oncotarget; 2015 Oct; 6(30):28731-42. PubMed ID: 26353933
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the Oncogenic Potential of VAV1 in Human Cancer: Lessons from Mouse Models.
Shalom B; Salaymeh Y; Risling M; Katzav S
Cells; 2023 Apr; 12(9):. PubMed ID: 37174676
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic Vav1 induces Rac-dependent apoptosis via inhibition of Bcl-2 family proteins and collaborates with p53 deficiency to promote hematopoietic progenitor cell proliferation.
Gu Y; Siefring JE; Wang L; Chae HD; Bailey JR; Zheng Y
Oncogene; 2006 Jun; 25(28):3963-72. PubMed ID: 16474842
[TBL] [Abstract][Full Text] [Related]
6. Mutation of Vav1 adaptor region reveals a new oncogenic activation.
Razanadrakoto L; Cormier F; Laurienté V; Dondi E; Gardano L; Katzav S; Guittat L; Varin-Blank N
Oncotarget; 2015 Feb; 6(4):2524-37. PubMed ID: 25426554
[TBL] [Abstract][Full Text] [Related]
7. Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies.
Katzav S
Cancer Lett; 2007 Oct; 255(2):241-54. PubMed ID: 17590270
[TBL] [Abstract][Full Text] [Related]
8. Vav1 Promotes B-Cell Lymphoma Development.
Shalom B; Farago M; Salaymeh Y; Sebban S; Pikarsky E; Katzav S
Cells; 2022 Mar; 11(6):. PubMed ID: 35326399
[TBL] [Abstract][Full Text] [Related]
9. An active form of Vav1 induces migration of mammary epithelial cells by stimulating secretion of an epidermal growth factor receptor ligand.
Wilsbacher JL; Moores SL; Brugge JS
Cell Commun Signal; 2006 May; 4():5. PubMed ID: 16709244
[TBL] [Abstract][Full Text] [Related]
10. The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis.
Lazer G; Idelchuk Y; Schapira V; Pikarsky E; Katzav S
J Pathol; 2009 Sep; 219(1):25-34. PubMed ID: 19533802
[TBL] [Abstract][Full Text] [Related]
11. The association of Sam68 with Vav1 contributes to tumorigenesis.
Lazer G; Pe'er L; Schapira V; Richard S; Katzav S
Cell Signal; 2007 Dec; 19(12):2479-86. PubMed ID: 17855053
[TBL] [Abstract][Full Text] [Related]
12. Vav1: a hematopoietic signal transduction molecule involved in human malignancies.
Katzav S
Int J Biochem Cell Biol; 2009 Jun; 41(6):1245-8. PubMed ID: 19100858
[TBL] [Abstract][Full Text] [Related]
13. Role of vav1 in the lipopolysaccharide-mediated upregulation of inducible nitric oxide synthase production and nuclear factor for interleukin-6 expression activity in murine macrophages.
Godambe SA; Knapp KM; Meals EA; English BK
Clin Diagn Lab Immunol; 2004 May; 11(3):525-31. PubMed ID: 15138177
[TBL] [Abstract][Full Text] [Related]
14. The hemopoietic Rho/Rac guanine nucleotide exchange factor Vav1 regulates N-formyl-methionyl-leucyl-phenylalanine-activated neutrophil functions.
Kim C; Marchal CC; Penninger J; Dinauer MC
J Immunol; 2003 Oct; 171(8):4425-30. PubMed ID: 14530369
[TBL] [Abstract][Full Text] [Related]
15. Guanine exchange-dependent and -independent effects of Vav1 on integrin-induced T cell spreading.
del Pozo MA; Schwartz MA; Hu J; Kiosses WB; Altman A; Villalba M
J Immunol; 2003 Jan; 170(1):41-7. PubMed ID: 12496381
[TBL] [Abstract][Full Text] [Related]
16. Vav1 regulates MHCII expression in murine resting and activated B cells.
Jux B; Staratschek-Jox A; Penninger JM; Schultze JL; Kolanus W
Int Immunol; 2013 May; 25(5):307-17. PubMed ID: 23391492
[TBL] [Abstract][Full Text] [Related]
17. Rho guanosine nucleotide exchange factors are not such bad guys after all in cancer
Robles-Valero J; Lorenzo-Martín LF; Fernández-Pisonero I; Bustelo XR
Small GTPases; 2020 Jul; 11(4):233-239. PubMed ID: 29313423
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase regulates T cell activity through Vav1/Rac pathway.
Li R; Li H; Sun Q; Liu L; Zhang C; Ren X
Mol Immunol; 2017 Jan; 81():102-107. PubMed ID: 27930920
[TBL] [Abstract][Full Text] [Related]
19. Recognition and activation of Rho GTPases by Vav1 and Vav2 guanine nucleotide exchange factors.
Heo J; Thapar R; Campbell SL
Biochemistry; 2005 May; 44(17):6573-85. PubMed ID: 15850391
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin is an oncogenic Vav1- but not wild-type Vav1-responsive gene: implications for fibroblast transformation.
Schapira V; Lazer G; Katzav S
Cancer Res; 2006 Jun; 66(12):6183-91. PubMed ID: 16778192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]